Overexpression of the apoptosis inhibitor FLIP in T cells correlates with disease activity in multiple sclerosis

Journal of Neuroimmunology

Volumn 113, Issue 2, 2001, Pages 268-274

  Semra, Y K ^a   Seidi, O A ^a   Sharief, M K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Apoptosis; Disease activity; FLIP; Multiple sclerosis

Indexed keywords

APOPTOSIS INHIBITOR; FLICE INHIBITORY PROTEIN; UNCLASSIFIED DRUG;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; HUMANS; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NERVOUS SYSTEM DISEASES; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-BCL-2; REFERENCE VALUES; T-LYMPHOCYTES;

EID: 0035866004     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(00)00443-4     Document Type: Article

References (47)

1. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis
2. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
3. High levels of bcl-2 protein in circulating T lymphocytes, but not B lymphocytes, of patients with SLE
4. Serum sAPO-1/Fas levels in multiple sclerosis
5. TNF, apoptosis and autoimmunity: A common thread?
6. Expression of Bcl-2, Bcl-x, and Bax after T cell activation and IL-2 withdrawal
7. Portrait of an executioner: The molecular mechanism of FAS/APO-1-induced apoptosis
8. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients
9. Decreased Fas function in MS
10. Multiple sclerosis: Fas signaling in oligodendrocyte cell death
11. IAP family proteins: Suppressors of apoptosis
12. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain
13. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis
14. Immunosuppressive properties of methotrexate: Apoptosis and clonal deletion of activated peripheral T cells
15. Analysis of the role of bcl-2 in apoptosis
16. The role of the Bcl-2 family of apoptosis regulatory proteins in the immune system
17. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells
18. Detection of the soluble form of the Fas molecule in patients with MS and human T-lymphotropic virus type I-associated myelopathy
19. Inhibition of death receptor signals by cellular FLIP
20. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
21. Expression of a murine homologue of the inhibitor of apoptosis protein is related to cell proliferation
22. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis
23. Detection of human white cell proliferative responses by immunoenzymatic measurement of bromodeoxyuridine uptake
24. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis
25. Fas/APO-1/CD95 in health and autoimmune disease: Thymic and peripheral aspects
26. The role of programmed cell death as an emerging new concept for the pathogenesis of autoimmune diseases
27. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes
28. Genetically determined failure of activation-induced apoptosis of autoreactive T cells as a cause of multiple sclerosis
29. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis
30. Resistance of cultured peripheral T cells towards activation-induced cell death involves a lack of recruitment of FLICE (MACH/caspase 8) to the CD95 death-inducing signaling complex
31. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity
32. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases
33. Apoptosis signaling in lymphocytes
34. The role of c-FLIP in modulation of CD95-induced apoptosis
35. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis
36. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with MS
37. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis
38. Fas-mediated apoptosis in clinical remissions of relapsing experimental autoimmune encephalomyelitis
39. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors
40. The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations
41. Apoptosis. Placing death under control
42. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP
43. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway
44. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis
45. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand
46. CD95 expression and CD95-mediated apoptosis of T cells in multiple sclerosis. No differences from normal individuals and no relation to HLA-DR2
47. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis